Inogen, Inc

INGN Healthcare Medical Devices

Inogen, Inc’s revenue for fiscal 2025 (year ended December 2025) was $348.7 million, up 3.86% from fiscal 2024. In the quarter to June 2026, revenue grew 3.04%, EPS grew 6.67% and free cash flow fell 51.2%, each against the same quarter a year earlier.

6.25 0.05 −0.79%
Market cap
$167.1M
P/E
0.0×
Fwd P/E
−8.2×
Dividend yield
—
F-score
5/9
Altman Z
1.56
Beneish M
−2.32
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
8 5 8 4 3 5 3 3 6 5
P/E ratio
64.56 117.99 50.89 71.18 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
27.30 32.90 26.57 10.57 6.71 5.49 3.41 0.48 1.44 1.56
P/S ratio
6.49 9.88 7.37 4.12 3.18 2.14 1.20 0.42 0.65 0.51
P/FCF ratio
45.10 45.52 54.71 40.09 30.34 42.44 0.00 0.00 467.47 0.00
Altman Z″-Score (non-manufacturers)
10.76 10.38 10.86 7.96 7.17 7.43 5.25 1.06 1.25 2.26
P/Operating CF
253.84 189.49 214.05 158.81 60.63 117.68 (29.33) (41.74) (71.87) (189.57)
Beneish M-Score
(2.17) (3.25) (2.31) (1.94) (3.10) (2.98) (1.87) (4.17) (3.51) (2.32)
P/B ratio
7.22 10.86 8.51 4.33 2.81 2.07 1.53 0.64 1.25 0.93
EV/Sales
5.92 9.19 6.70 3.54 2.43 1.45 0.71 0.01 0.30 0.17
EV/EBITDA
32.99 57.43 48.80 38.13 114.55 16.82 0.00 0.00 0.00 0.00
EV/FCF
41.20 42.31 49.73 34.47 23.20 28.82 (6.53) (0.35) 214.77 (3.27)
Current Ratio
7.07 6.74 6.75 5.82 5.39 5.35 4.66 2.86 2.42 3.12
Net Debt/EBITDA
(3.13) (4.36) (4.89) (6.22) (35.27) (7.95) 3.03 1.41 5.46 12.66
Debt/Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
12.98% 10.27% 19.29% 6.40% (1.68%) (1.76%) (25.10%) (40.80%) (18.95%) (12.43%)
ROA
10.93% 8.59% 15.93% 5.09% (1.28%) (1.33%) (18.73%) (28.02%) (11.53%) (7.65%)
ROIC
20.95% 32.48% 33.80% 9.13% (6.35%) 4.63% (48.26%) (89.55%) (47.08%) (26.45%)
Return on Tangible Assets
12.52% 9.78% 17.86% 8.01% (2.10%) (2.07%) (29.65%) (55.41%) (23.43%) (13.29%)
Average Days of Receivables
56.26 47.93 40.46 37.62 37.58 26.30 62.26 49.62 32.14 40.68
Earnings Yield
1.55% 0.85% 1.97% 1.40% (0.58%) (0.79%) (18.42%) (77.78%) (16.58%) (12.80%)
Free Cash Flow Yield
2.22% 2.20% 1.83% 2.49% 3.30% 2.36% (9.01%) (6.81%) 0.21% (9.95%)
Free Cash Flow per Share
1.46 2.62 2.43 1.70 1.47 0.80 (1.79) (0.39) 0.02 (0.52)
Book value per Share
9.07 10.98 14.60 15.79 15.91 16.46 13.01 8.84 7.35 7.23
Free Cash Flow
29.20 54.26 51.58 37.20 32.37 18.02 (40.87) (8.95) 0.46 (13.74)
EV/EBIT
52.56 83.04 63.35 64.79 0.00 56.20 0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates